Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 45 | 1 | 35 | −9 |
| Shares | 10.2M | 143.6K | 9.16M | −928.2K (−9.2%) |
| Value | $39.6M | $556.0K | $25.4M | −$13.7M (−35.0%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 19,729 | $55.0K | 0.00% |
| Coastal Bridge Advisors, LLC | 11,900 | $32.0K | 0.01% |
| Simplex Trading, LLC | 8,134 | $22.0K | 0.00% |
Sold out (12)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Altium Capital Management LP | 785,341 | $3.04M |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556.0K |
| Millennium Management LLC | 139,477 | $540.0K |
| Gsa Capital Partners LLP | 85,993 | $333.0K |
| Virtu Financial LLC | 14,938 | $58.0K |
| Goldman Sachs Group Inc | 10,755 | $42.0K |
| Lindbrook Capital, LLC | 2,000 | $8.00K |
| Tower Research Capital LLC (TRC) | 445 | $2.00K |
| JPMorgan Chase & Co | 223 | $1.00K |
| Deutsche Bank AG | 131 | $1.00K |
| O'Shaughnessy Asset Management, LLC | 54 | $0 |
| UBS Group AG | 85 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Psagot Investment House Ltd. | 143,591 | $556.0K |